[1]
Veli Yazısız et al. 2021. The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients. Archives of Rheumatology. 36, 3 (Sep. 2021), 366–374. DOI:https://doi.org/10.46497/ArchRheumatol.2021.8500.